10 giugno 2022 – The European Medical Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) approved a new manufacturing site for the active substance of Jcovden. Jcovden is a vaccine for preventing Covid-19 in people aged 18 years and older. Jcovden is made up of another virus that has been modified to contain the gene for making a protein found on SARS-CoV-2.

For more information, see here.